Dr Tim Wells, MMV’s Chief Scientific Officer and two of MMV’s Board Members, Dr Pedro Alonso [1] and Prof Win Gutteridge [2], distinguished contributors to fighting malaria in their own right, have co-authored a new article “New medicines to improve control and contribute to the eradication of malaria” which appears this month in Nature Reviews Drug Discovery. This comprehensive article addresses the question of what is at the cutting edge today in the antimalarial world, and what drugs are coming out of the pipeline to help fight the emergence and spread of resistance to current antimalarials and to answer the recent call for elimination and eradication of malaria.

Nature Reviews Drug Discovery has graciously allowed us to make the PDF of this important article available to the wider public.

New medicines to improve control and contribute to the eradication of malaria [PDF: 539Kb]
co-authored by Dr Tim Wells, CSO and Dr Pedro Alonso and Prof Win Gutteridge, MMV Board Members 
Nature Reviews Drug Discovery 
November 2009 Volume 8, Number 11, pp 879-891 

Link to abstract on Nature.com

[1] Dr Alonso is at the Barcelona Centre for International Health Research, Hospital Clinic/IDIBAPS, Universitat de Barcelona, Barcelona, Spain, and Centro de Investigação em Saúde de Manhiça, Manhiça, Maputo, Mozambique

[2] Prof Win Gutteridge helped co-found MMV in 1999, and has served as the Chairman of MMV’s Expert Scientific Advisory Committee (ESAC) and also as a Member of the MMV Board of Directors. He is currently also Consulting and Visiting Professor at the London School of Hygiene and Tropical Medicine (LSHTM)